K. Taylor

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies

Barry D. Hock, Lisa F. Haring, Alexander Steinkasserer et al. · Leukemia Research · 2003 · 68 citations

Medicine, Hematology, Immunology +9

Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies

Barry D. Hock, Judith L. McKenzie, Nigel Patton et al. · Cancer · 2006 · 58 citations · Full text

Medicine, Hematology, Immunology +17

Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients

Barry D. Hock, J. L. O'Donnell, K. Taylor et al. · Tissue Antigens · 2005 · 54 citations

Life Sciences, Clinical Sciences, Immunology +16

Effect of activated human polymorphonuclear leucocytes on <scp>T</scp> lymphocyte proliferation and viability

Barry D. Hock, K. Taylor, Nicholas Cross et al. · Immunology · 2012 · 48 citations · Full text

Life Sciences, Immunology, Pathology +13

Phase Ib study of oral panobinostat (LBH589) plus lenalidomide (LEN) plus dexamethasone (DEX) in patients (Pts) with relapsed (Rel) or Rel and refractory (Ref) multiple myeloma (MM).

María‐Victoria Mateos, Andrew Spencer, K. Taylor et al. · Journal of Clinical Oncology · 2010 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +13